Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$18.95 - $23.95 $1.11 Million - $1.41 Million
-58,814 Closed
0 $0
Q4 2020

Feb 08, 2021

BUY
$24.81 - $30.33 $381,677 - $466,596
15,384 Added 35.42%
58,814 $1.67 Million
Q3 2020

Nov 12, 2020

SELL
$30.28 - $35.72 $87,690 - $103,445
-2,896 Reduced 6.25%
43,430 $1.36 Million
Q2 2020

Jul 17, 2020

BUY
$24.08 - $33.35 $138,146 - $191,328
5,737 Added 14.13%
46,326 $1.47 Million
Q1 2020

May 12, 2020

SELL
$18.86 - $37.36 $52,732 - $104,458
-2,796 Reduced 6.44%
40,589 $997,000
Q4 2019

Feb 11, 2020

SELL
$26.07 - $36.32 $346,861 - $483,237
-13,305 Reduced 23.47%
43,385 $1.55 Million
Q3 2019

Nov 13, 2019

SELL
$24.18 - $31.58 $39,171 - $51,159
-1,620 Reduced 2.78%
56,690 $1.56 Million
Q2 2019

Aug 12, 2019

BUY
$23.24 - $26.76 $70,672 - $81,377
3,041 Added 5.5%
58,310 $1.41 Million
Q1 2019

May 08, 2019

SELL
$22.55 - $29.84 $32,787 - $43,387
-1,454 Reduced 2.56%
55,269 $1.26 Million
Q4 2018

Feb 14, 2019

SELL
$21.96 - $31.02 $552,908 - $781,021
-25,178 Reduced 30.74%
56,723 $1.44 Million
Q3 2018

Nov 14, 2018

SELL
$26.64 - $35.66 $156,430 - $209,395
-5,872 Reduced 6.69%
81,901 $2.19 Million
Q2 2018

Aug 14, 2018

BUY
$25.15 - $30.6 $2.21 Million - $2.69 Million
87,773 New
87,773 $2.66 Million

Others Institutions Holding MOR

About MorphoSys AG


  • Ticker MOR
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 136,614,000
  • Description
  • MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...
More about MOR
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.